Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Ethical Hurdles in the Prioritization of Oncology Care.

de Groot F, Capri S, Castanier JC, Cunningham D, Flamion B, Flume M, Herholz H, Levin LÅ, Solà-Morales O, Rupprecht CJ, Shalet N, Walker A, Wong O.

Appl Health Econ Health Policy. 2017 Apr;15(2):119-126. doi: 10.1007/s40258-016-0288-4.

2.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Fürst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahović-Palčevski VV, Markovic-Pekovic V, Vončina L, Malinowska K, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 17;5:106. doi: 10.3389/fphar.2014.00106. eCollection 2014. Review.

3.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Review.

4.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

5.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

6.

Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea.

Scheid L, Ellinger S, Alteheld B, Herholz H, Ellinger J, Henn T, Helfrich HP, Stehle P.

J Nutr. 2012 Dec;142(12):2091-6. doi: 10.3945/jn.112.166371. Epub 2012 Oct 24.

PMID:
23096008
7.

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, McGinn D, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22. doi: 10.1586/erp.10.72.

PMID:
21155704
8.

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Adamski J, Godman B, Ofierska-Sujkowska G, Osińska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson R, Garuolienè K, Haycox A, Garattini S, Gustafsson LL.

BMC Health Serv Res. 2010 Jun 7;10:153. doi: 10.1186/1472-6963-10-153. Review.

9.

[Evaluation of special GP-centered health care contracts in Germany by the participating GPs. present situation and future perspectives].

Klingenberg A, Broge B, Herholz H, Szecsenyi J, Ose D.

Med Klin (Munich). 2010 Feb;105(2):89-95. doi: 10.1007/s00063-010-1012-8. Epub 2010 Feb 20. German.

PMID:
20174908
10.

Policies to enhance prescribing efficiency in europe: findings and future implications.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, Lonsdale J, Malmström RE, Martikainen JE, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL.

Front Pharmacol. 2011 Jan 7;1:141. doi: 10.3389/fphar.2010.00141. eCollection 2010.

11.

The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.

Dicker F, Herholz H, Schnittger S, Nakao A, Patten N, Wu L, Kern W, Haferlach T, Haferlach C.

Leukemia. 2009 Jan;23(1):117-24. doi: 10.1038/leu.2008.274. Epub 2008 Oct 9.

PMID:
18843282
12.

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype.

Haferlach C, Dicker F, Herholz H, Schnittger S, Kern W, Haferlach T.

Leukemia. 2008 Aug;22(8):1539-41. doi: 10.1038/leu.2008.143. Epub 2008 Jun 5.

PMID:
18528419
13.

Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.

Herholz H, Kern W, Schnittger S, Haferlach T, Dicker F, Haferlach C.

Cancer Genet Cytogenet. 2007 Apr 1;174(1):57-60.

PMID:
17350468
14.

[5th Report of the German Association of Cardiologists in Private Practice (BNK) on Quality Assurance in Cardiac Catheterization and Coronary Intervention 2003-2005].

Levenson B, Albrecht A, Göhring S, Haerer W, Herholz H, Reifart N, Sauer G, Troger B.

Herz. 2007 Feb;32(1):73-84. German.

PMID:
17323039
15.

[Sample survey of persons insured in statutory health insurance institutions in Hessen--concept and realisation of person-related data base].

Ihle P, Köster I, Herholz H, Rambow-Bertram P, Schardt T, Schubert I.

Gesundheitswesen. 2005 Aug-Sep;67(8-9):638-45. German.

PMID:
16217718
16.

[The German Quality Management System for Outpatient Care (Q-M-A) Checklist--an instrument for assessing quality management systems in outpatient care].

Thomeczek C, Birkner B, Everz D, Gass S, Gramsch E, Hellmann A, Herholz H, Oesingmann U, Gibis B, Stobrawa F, Weidringer JW, Ollenschläger G.

Gesundheitswesen. 2003 Oct;65(10):585-92. German.

PMID:
14571366
17.

[Curriculum for "structured medical care"].

Eberlein-Gonska M, Löw A, Herholz H.

Z Arztl Fortbild Qualitatssich. 2003 Jun;97(3):215-8. German.

PMID:
12856549
18.

[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002].

Levenson B, Albrecht A, Göhring S, Haerer W, Herholz H, Kaltenbach M, Reifart N, Sauer G, Silber S, Troger B; QulK-Register des Bundesverbandes Niedergelassener Kardiologen.

Herz. 2003 Jun;28(4):335-47. German.

PMID:
12825149
19.

[Evaluation of invasive cardiologic procedures].

Schräder R, Spies HF, Herholz H.

Z Arztl Fortbild Qualitatssich. 2003 Feb;97(1):73-5. German. No abstract available.

PMID:
12669693
20.

Qualitätssicherung und Qualitätsmanagement in der ambulanten Versorgung am Beispiel Hessen.

Herholz H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2002 Mar;45(3):249-59. doi: 10.1007/s00103-002-0379-2. German.

PMID:
24676920

Supplemental Content

Loading ...
Support Center